Does AXITINIB Cause Neoplasm malignant? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Neoplasm malignant have been filed in association with AXITINIB (INLYTA). This represents 0.8% of all adverse event reports for AXITINIB.
134
Reports of Neoplasm malignant with AXITINIB
0.8%
of all AXITINIB reports
32
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm malignant From AXITINIB?
Of the 134 reports, 32 (23.9%) resulted in death, 11 (8.2%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which AXITINIB Alternatives Have Lower Neoplasm malignant Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE